Receipt of Routine Vaccines May Be Predictive of COVID-19 Vaccination Status
Drug Topics
OCTOBER 20, 2022
Adults who receive influenza and pneumococcal vaccines may be more likely to receive COVID-19 vaccines and boosters.
Thu.Oct 20, 2022
488 
Three ways 340B is failing vulnerable patients
PhRMA
OCTOBER 20, 2022
The 340B Drug Pricing Program is 30 years old this year, but as The New York Times recently spelled out , the program has become a profit engine for large health systems over the years instead of a program that helps vulnerable, low-income patients. Powerful hospitals have twisted the program to boost their bottom line.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
J&J reveals just how much economic turbulence is affecting Big Pharma
PharmaVoice
OCTOBER 20, 2022
The healthcare giant showed pharmaceutical gains, but that's no thanks to the economic environment of persistent inflation and a strong U.S. dollar.
Latest Research: COVID-19 Vaccines
Drug Topics
OCTOBER 20, 2022
A selection of the latest COVID-19 vaccine research out of IDWeek 2022.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
How a company aimed at bringing the woolly mammoth back to life spun off a startup that could speed drug development
PharmaVoice
OCTOBER 20, 2022
Colossal Biosciences announced the creation of Form Bio — and its “operating system for science” — in September.
Examining Factors That Impact Antibiotic Prescribing in Urgent Care
Drug Topics
OCTOBER 20, 2022
Determining the characteristics that impact antibiotic prescribing behavior is important for addressing health inequity.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
NCPA Urges Department of Defense to Address Pharmacy Access Restrictions for Tricare Beneficiaries
Drug Topics
OCTOBER 20, 2022
The new restrictions include both independent and chain pharmacies.
Tackling immune-mediated disease with CAR Tregs
European Pharmaceutical Review
OCTOBER 20, 2022
In recent years there has been significant development within the cell therapy field, as chimeric antigen receptor (CAR) T-cell therapy demonstrated an ability to transform the treatment of patients with haematological malignancies. Recognising the potential of CAR T cells to act as highly targeted therapeutics, several biotechnology companies – including Sangamo Therapeutics – have established development pipelines of CAR T regulatory cells (Tregs) that aim to tackle immune?
Implications of Current Maternal Tdap Vaccine Uptake on Future Vaccines
Drug Topics
OCTOBER 20, 2022
What does the uptake look like for one of the most common vaccines given during pregnancy—and what does this mean for the future?
Expert: Pharmacists Are ‘Very Involved in Holistic Care of Patients With Multiple Myeloma,’ Beyond Treatment Alone
Pharmacy Times
OCTOBER 20, 2022
Rachel K. Anderson, PharmD, CSP, clinical program manager at Alliance Rx Walgreens Pharmacy, discusses the impact pharmacists have on the care journey for patients with multiple myeloma.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Frontiers Health 2022 – day 2
pharmaphorum
OCTOBER 20, 2022
And the LIVE coverage continues as we head into Day Two… This day is set to hold even more points of interest, with the demonstration ‘CX innovation: building experiences that work for customers’ (moderated by Healthware Group’s global head of digital strategy and customer engagement Yannick Valenti), as well as the masterclass ‘How to maximise learning science to affect behaviour change’ with Meducate Global’s president, Lawrence Sherman, and MD of Healthware MedComms & SWM, Francis M
Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 3 with Timothy Gauthier
Pharmacy Times
OCTOBER 20, 2022
Staying informed through the right sources and being mindful of antibiotic usage can help health care providers and patients be more prepared for future pandemics.
Tobacco companies shower Black Democrats with campaign cash
STAT
OCTOBER 20, 2022
WASHINGTON — Tobacco companies generally don’t donate to many Democratic candidates for political office. But this election cycle, Black Democrats in particular are getting showered with campaign cash from cigarette makers. Reynolds American, which is behind the Newport and Camel brands, has donated to 17 Democrats this election cycle, more than two thirds of whom are Black members of Congress, according to data published by the Center for Responsive Politics in late September.
Study Supports Deutetrabenazine for Treatment of Chorea Associated with Huntington Disease
Pharmacy Times
OCTOBER 20, 2022
Deutetrabenazine is the only VMAT2 inhibitor approved by the FDA for the treatment of tardive dyskinesia in adults and for the treatment of chorea associated with Huntington disease.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT+: As AI grows in medical image analysis, concern about building trust with doctors grows too
STAT
OCTOBER 20, 2022
In 2018, the researcher Pranav Rajpurkar was working on an algorithm that could find blood clots in patients’ legs from ultrasound images. It spotted them very well, but when he went looking for what the algorithm had picked up on in the images to make its predictions, he saw it had been cheating: it was looking at the metadata in the top right corner of every ultrasound.
Experts Discuss Differences in Role of Pharmacy Technicians in Various Countries
Pharmacy Times
OCTOBER 20, 2022
In a panel, pharmacy technicians across the world discuss the differences of the role for pharmacy technicians in United States, Portugal, and the United Kingdom.
U.S. surgeon general says workplaces are taking a toll on Americans’ mental and physical health
STAT
OCTOBER 20, 2022
Your job can be hazardous to your health, according to a new report from the U.S. Surgeon General that highlights how the Covid-19 pandemic has revealed fractures in working Americans’ mental health and well-being. Released Thursday, the report cites workplace trends like quiet quitting and the Great Resignation as signals of the damage done to Americans by problems like endless hours, unpaid leave, and chronic stress.
An Annex 1 and Pharma 4.0 perspective on water quality
European Pharmaceutical Review
OCTOBER 20, 2022
An essential part of the manufacturing of drug products is the use of water of different degrees of purity. The US Food and Drug Administration (FDA) defines eight different types of water: non-potable, potable (drinkable), purified, water for injection (WFI), sterile water for injection, sterile water for inhalation, bacteriostatic water for injection and sterile water for irrigation. 1 The last four are produced at separate plants and thus less discussed for pharma since they are unlikely to b
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
‘Front of the line’: For Alzheimer’s patients in successful trial, a feeling of gratitude
STAT
OCTOBER 20, 2022
When the news came out last month that an experimental Alzheimer’s therapy succeeded in a clinical trial , it provided a rare boost of hope for the millions facing the condition. A select group of patients felt something more: lucky. In interviews, people who participated in the trial and their caregivers described a gratitude at somehow winding up in a study where the drug actually worked, against a backdrop of repeated failures to develop effective Alzheimer’s medications.
Achieving commercial excellence with data-driven decisions
pharmaphorum
OCTOBER 20, 2022
Executing an effective commercial success strategy requires extensive planning and implementation within pharmaceutical companies that spans teams, functions, and geographies. Together, these groups compile vast amounts of data, including rich information on patient populations, target customers, and the competitive landscape. But after months of effort, in most cases, the usefulness of this data begins and ends in a static slide deck or spreadsheet.
STAT+: Novartis agrees to license a best-selling cancer drug to dozens of low- and middle-income countries
STAT
OCTOBER 20, 2022
Amid a push to widen access to medicines to poor countries, Novartis has reached an agreement to license one of its best-selling cancer treatments so that generic manufacturers can produce copies for distribution to 44 low- and middle-income nations. The deal with the Medicines Patent Pool, a public health organization backed by the United Nations, marks the first time that a voluntary licensing deal has been arranged for a cancer medication.
First oral combined estetrol contraceptive available in UK
European Pharmaceutical Review
OCTOBER 20, 2022
Gedeon Richter has announced that its combined oral contraceptive Drovelis® is the first tablet containing estetrol (E4) and drospirenone (DRSP) to be made available on the NHS in England. The drug (14.2mg estetrol and 3mg drospirenone) is the first oral combined contraceptive containing a new, synthetic natural oestrogen to be offered to patients in the UK.
Opinion: How states can act to limit drug price increases, saving employers and workers billions
STAT
OCTOBER 20, 2022
The Inflation Reduction Act of 2022 mandates that Medicare-covered drug sales will be protected from price increases that exceed inflation, but the mechanics of this “inflation penalty” have generated some confusion. A top Medicare official recently noted that the per-pill value of the Medicare inflation penalty will be calculated based on average prices across both the Medicare and commercial markets, but the penalty will be paid only on prescriptions reimbursed by Medicare.
Live from Reuters Pharma 2022 – the pharmaphorum podcast
pharmaphorum
OCTOBER 20, 2022
In mid-October, our Web Editor Nicole Raleigh and Deep Dive Editor Eloise McLennan travelled to Nice for the Reuters Pharma event. This special episode includes a conversation recorded on-site with Nicole, Eloise, Virtual Science AI CEO Thomas Hughes, and VSAI VP of global patient affairs Geraldine Reilly. They discuss key takeaways from the event, major trends in the space, and the guests’ work at Virtual Science AI, using technology to help life sciences companies create virtual patient adviso
STAT+: Dozens of institutional investors urge drugmakers to link executive compensation to access to medicines
STAT
OCTOBER 20, 2022
Three dozen institutional investors are urging the boards at several of the world’s largest pharmaceutical companies to establish concrete metrics for linking executive compensation with policies that widen access to medicines to low- and middle-income countries. In a series of letters, the investors asked the heads of board compensation committees to examine such steps as voluntary licensing agreements and technology transfer for generic production; supply chain performance for improving
Full data set for new buffer stock blending system freely available
European Pharmaceutical Review
OCTOBER 20, 2022
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and BioPhorum have announced that the data and design specification for a novel Buffer Stock Blending System are now a publicly available open-source resource. The new current good manufacturing practices (cGMP) buffer technology is designed to deliver buffer on-demand commercially to save labour costs and cost per litre compared to traditional buffer preparation.
BU’s Covid tinkering, FDA on trial, & why it’s hard to take drugs off the market
STAT
OCTOBER 20, 2022
What happens when approved drugs turn out not to work? Is it OK to make SARS-CoV-2 hybrids? And are British tabloids reliable sources of science news? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Lawyer and bioethicist Holly Fernandez Lynch joins us to explain a watershed test of the FDA’s authority to revoke drug approvals.
Technicians Perform Vital Role in Academia
Pharmacy Times
OCTOBER 20, 2022
Improved workflow and optimal patient outcomes occur when technicians serve as vital members of the health care team, across the continuum of care.
STAT+: How one pharma insider sees the drug pricing reform law: the impact will ‘vary by product and by company’
STAT
OCTOBER 20, 2022
After years of stops and starts, a law was finally passed in Congress this summer to address the rising cost of prescription medicines. The Inflation Reduction Act allows the federal government to negotiate prices for some costly drugs, but only a small number that cost the government the most money. But those medicines can’t have any competing products on the market, and negotiations can’t begin until a small-molecule drug has been available for at least nine years and a biologic
Forge adds plasmid DNA manufacturing to integrate gene therapy production service
Outsourcing Pharma
OCTOBER 20, 2022
Forge Biologics has added plasmid DNA manufacturing to its roster of services, enabling it to vertically integrate its production process.
STAT+: Pharmalittle: Pharma tries to blunt Medicare power to negotiate prices; FDA panel supports withdrawal of premature birth drug
STAT
OCTOBER 20, 2022
Top of the morning to you. Another deliciously shiny day is unfolding over the Pharmalot campus, where the skies are blue and a cool breeze is circulating. Although there is much work to be done, please join us as we pause ever so briefly to relish the moment with a tasty cup of stimulation — our choice today is peppermint mocha. After all, life is short, so why not stop to appreciate, yes?
Sonidegib, a Hedgehog Signaling Pathway Inhibitor for Locally Advanced Basal Cell Carcinoma
Pharmacy Times
OCTOBER 20, 2022
Sonidegib binds to and inhibits a transmembrane protein to disrupt hedgehog pathway signal transduction and leading to antitumor activity in patients with locally advanced basal cell carcinoma.
Cancer diagnoses decrease across England during 2020
Pharma Times
OCTOBER 20, 2022
Statistics show an average of 789 new malignant cancers diagnosed per day in 2020
Let's personalize your content